CLVT241220P7500
- 1.10
- 0.000.00%
Clarivate Newsroom
Worst Performing Stocks for Tax Loss Selling – Wolfe
Press Release: Clarivate Announces New $500 Million Share Repurchase Authorization
Clarivate Announces New $500 Million Share Repurchase Authorization >CLVT
Morgan Stanley Remains a Hold on Clarivate (CLVT)
Clarivate Launches AI-Powered Patent Search Solution in Derwent
Revenues Not Telling The Story For Clarivate Plc (NYSE:CLVT) After Shares Rise 25%
RBC Capital Sticks to Their Hold Rating for Clarivate (CLVT)
Here's Why Clarivate (NYSE:CLVT) Has A Meaningful Debt Burden
Daikin Selects IPfolio From Clarivate
BridgeBio Pharma, Rigetti Computing, Bath & Body Works And Other Big Stocks Moving Higher On Monday
Clarivate Insider Bought Shares Worth $17,863,350, According to a Recent SEC Filing
Express News | Four scientists from Muyuan Laboratory were selected for the 2024 'Global Highly Cited Scientists' list.
Clarivate(CLVT.US) Director Buys US$17.86 Million in Common Stock
$Clarivate(CLVT.US)$ Director Angelakis Michael J purchased 3.47 million shares of common stock on Nov 20, 21, 22, 2024 at an average price of $5.16 for a total value of $17.86 million.Source:
Angelakis Buys $17.86 Million in Clarivate Shares
Clarivate Healthcare Business Insights Unveils 2023 Revenue Cycle Award Winners
Clarivate Third Quarter 2024 Earnings: Misses Expectations
US$6.27: That's What Analysts Think Clarivate Plc (NYSE:CLVT) Is Worth After Its Latest Results
Should You Think About Buying Clarivate Plc (NYSE:CLVT) Now?
Goldman Sachs Maintains Clarivate(CLVT.US) With Buy Rating, Announces Target Price $5.9
A Quick Look at Today's Ratings for Clarivate(CLVT.US), With a Forecast Between $4 to $8